156 related articles for article (PubMed ID: 38229877)
61. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
62. A Prospective Study on Neural Biomarkers in Patients with Long-COVID Symptoms.
Vrettou CS; Vassiliou AG; Keskinidou C; Mourelatos P; Asimakos A; Spetsioti S; Diamantopoulos A; Jahaj E; Antonoglou A; Katsaounou P; Vassiliadi DA; Kotanidou A; Dimopoulou I
J Pers Med; 2024 Mar; 14(3):. PubMed ID: 38541055
[TBL] [Abstract][Full Text] [Related]
63. Neuropsychiatric phenotype of post COVID-19 syndrome in non-hospitalized patients.
Lier J; Stoll K; Obrig H; Baum P; Deterding L; Bernsdorff N; Hermsdorf F; Kunis I; Bräsecke A; Herzig S; Schroeter ML; Thöne-Otto A; Riedel-Heller SG; Laufs U; Wirtz H; Classen J; Saur D
Front Neurol; 2022; 13():988359. PubMed ID: 36237627
[TBL] [Abstract][Full Text] [Related]
64. Acute and chronic neuropsychiatric symptoms in novel coronavirus disease 2019 (COVID-19) patients: A qualitative review.
Smith CJ; Renshaw P; Yurgelun-Todd D; Sheth C
Front Public Health; 2022; 10():772335. PubMed ID: 36033820
[TBL] [Abstract][Full Text] [Related]
65. Anxiety and posttraumatic stress in post-acute sequelae of COVID-19: prevalence, characteristics, comorbidity, and clinical correlates.
Ferrando SJ; Lynch S; Ferrando N; Dornbush R; Shahar S; Klepacz L
Front Psychiatry; 2023; 14():1160852. PubMed ID: 37333906
[TBL] [Abstract][Full Text] [Related]
66. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
PHOSP-COVID Collaborative Group
Lancet Respir Med; 2022 Aug; 10(8):761-775. PubMed ID: 35472304
[TBL] [Abstract][Full Text] [Related]
67. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
68. Mental health symptoms in family members of COVID-19 ICU survivors 3 and 12 months after ICU admission: a multicentre prospective cohort study.
Heesakkers H; van der Hoeven JG; Corsten S; Janssen I; Ewalds E; Burgers-Bonthuis D; Rettig TCD; Jacobs C; van Santen S; Slooter AJC; van der Woude MCE; Zegers M; van den Boogaard M
Intensive Care Med; 2022 Mar; 48(3):322-331. PubMed ID: 35103824
[TBL] [Abstract][Full Text] [Related]
69. Post-acute COVID-19 functional movement disorder.
Garg A; Goyal S; Comellas AP
SAGE Open Med Case Rep; 2021; 9():2050313X211039377. PubMed ID: 34408879
[TBL] [Abstract][Full Text] [Related]
70. Cerebral biomarkers in neurologic complications of preeclampsia.
Bergman L; Hastie R; Bokström-Rees E; Zetterberg H; Blennow K; Schell S; Imberg H; Langenegger E; Moodley A; Walker S; Tong S; Cluver C
Am J Obstet Gynecol; 2022 Aug; 227(2):298.e1-298.e10. PubMed ID: 35257666
[TBL] [Abstract][Full Text] [Related]
71. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
72. COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study.
Guo P; Benito Ballesteros A; Yeung SP; Liu R; Saha A; Curtis L; Kaser M; Haggard MP; Cheke LG
Front Aging Neurosci; 2022; 14():804922. PubMed ID: 35370617
[TBL] [Abstract][Full Text] [Related]
73. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study.
Rass V; Beer R; Schiefecker AJ; Lindner A; Kofler M; Ianosi BA; Mahlknecht P; Heim B; Peball M; Carbone F; Limmert V; Kindl P; Putnina L; Fava E; Sahanic S; Sonnweber T; Löscher WN; Wanschitz JV; Zamarian L; Djamshidian A; Tancevski I; Weiss G; Bellmann-Weiler R; Kiechl S; Seppi K; Loeffler-Ragg J; Pfausler B; Helbok R
Eur J Neurol; 2022 Jun; 29(6):1685-1696. PubMed ID: 35239247
[TBL] [Abstract][Full Text] [Related]
74. Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up.
Kyzar EJ; Purpura LJ; Shah J; Cantos A; Nordvig AS; Yin MT
Brain Behav Immun Health; 2021 Oct; 16():100315. PubMed ID: 34345869
[TBL] [Abstract][Full Text] [Related]
75. Neurologic Outcomes of Survivors of COVID-19-Associated Acute Respiratory Distress Syndrome Requiring Intubation.
Jaquet P; Legouy C; Le Fevre L; Grinea A; Sinnah F; Franchineau G; Patrier J; Marzouk M; Wicky PH; Alexis Geoffroy P; Arnoult F; Vledouts S; de Montmollin E; Bouadma L; Timsit JF; Sharshar T; Sonneville R
Crit Care Med; 2022 Aug; 50(8):e674-e682. PubMed ID: 35132020
[TBL] [Abstract][Full Text] [Related]
76. The determinants of COVID-induced brain dysfunctions after SARS-CoV-2 infection in hospitalized patients.
Yasir S; Jin Y; Razzaq FA; Caballero-Moreno A; Galán-García L; Ren P; Valdes-Sosa M; Rodriguez-Labrada R; Bringas-Vega ML; Valdes-Sosa PA
Front Neurosci; 2023; 17():1249282. PubMed ID: 38260018
[TBL] [Abstract][Full Text] [Related]
77. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
78. Neuropsychiatric aspects of long COVID: A comprehensive review.
Kubota T; Kuroda N; Sone D
Psychiatry Clin Neurosci; 2023 Feb; 77(2):84-93. PubMed ID: 36385449
[TBL] [Abstract][Full Text] [Related]
79. Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19.
Vannorsdall TD; Brigham E; Fawzy A; Raju S; Gorgone A; Pletnikova A; Lyketsos CG; Parker AM; Oh ES
J Acad Consult Liaison Psychiatry; 2022; 63(2):133-143. PubMed ID: 34793996
[TBL] [Abstract][Full Text] [Related]
80. SARS-CoV-2/COVID-19 associated pediatric acute-onset neuropsychiatric syndrome a case report of female twin adolescents.
Efe A
Psychiatry Res Case Rep; 2022 Dec; 1(2):100074. PubMed ID: 36267397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
